期刊文献+

流式细胞光度术在膀胱肿瘤诊治中的意义 被引量:2

Flow cytometry in diagnosis and treatment of bladdertumor
原文传递
导出
摘要 应用流式细胞光度术对52例膀胱肿瘤139次膀胱冲洗液中瘤细胞的DNA含量进行了检测。检查结果与细胞学及病理分级进行了比较。结果表明:细胞学检查的准确性明显低于流式细胞DNA含量的检查。肿瘤病理分级越高,浸润越深,其瘤细胞内DNA异倍体含量越高。对于高异倍体膀胱肿瘤需行根治性膀胱全切;单纯电切或膀胱部分切除效果较差,既使术后应用膀胱内灌注化疗也有很高的复发率。流式细胞检测与膀胱肿瘤病理分级的相关性好,特别是在高分级肿瘤,但不能替代膀胱镜检查。 AbstractThe cellular DNA contents of 139 bladder irriga-tions from 52 cases of bladder tumors were determinedby flow cytometry. The results were compared withthose of pathological grading and exfoliative cytology.It is suggested that cytoIogical results were less accu-rate than DNA contents. High aneuploid DNA con-tents in tumor cells were marked by low grade anddeep penetration of the bladder tumor. Total cystecto-my was needed for bladder tumor with high aneuploidDNA,and partial cvstectomv and TURBT for that tu-mor showed high recurrence with instillation of BCG.The results showed that DNA content of tumor is cor-related with the nuclear grade , especially in poorly dif-ferentiated neoplasms,but fIow cvtometrv can not re-place cystOscopy eXamInatlon.
出处 《中华外科杂志》 CAS CSCD 北大核心 1994年第3期178-180,共3页 Chinese Journal of Surgery
基金 国家教委博士点科研基金
  • 相关文献

同被引文献19

  • 1陈冠峰,庞自力,许景东.膀胱移行细胞癌患者尿脱落细胞中生存素的检测及其意义[J].临床泌尿外科杂志,2006,21(1):51-53. 被引量:4
  • 2Smith SD,Wheeler MA,Plescia J,et al. Urine detection of survivin and diagnosis of bladder cancer[J]. JAMA,2001,285(3) :324 - 328.
  • 3Ku JH, Kwak C,Lee HS, et al. Expression of survivin, a noval in hibitor of apoptosis, in superficial Itransitional cell carcinoma a of the bladder[J] .J Urol,2004,171(2ptl):631-635.
  • 4Hausladen D A, Wheeler M A, Altieri D C, et al. Effect of intravesical treatment of transitional cell carcinoma with bacillus calmette - guerin and mitomycin C on urinary survivin levels and outcome[J]. Juro,2003,170( 1 ) :230 - 234.
  • 5Grossman HB,Messing E,Soloway M,et al. Detection of bladder cancer using a point of care protemic assay [J]. JAMA, 2005, 16(7):810 - 816.
  • 6Shariat SF, Casella R, Uiams FH, et al. Risk stratification for bladder tumor recurrence,stage and grade by urinary nulear matrix protein 22 and cytology[J]. Eur Urol,2004,45(3) :304 - 313.
  • 7Hantmannn SH, Lokeshwar VB, Schroeder GL, et al. Elevated tissue expression of hyaluronic acid and hyaluronidese validates the HA - HAase urine test for bladder cancer[J] .J Urol,2001,165(6ptl) :2068 - 2074.
  • 8Schroeder GL,Lorenzo Comez MF,Hantmann SH,et al.A side by comparison of cytology and biomarkers for bladder cancer detection [ J ]. J Urol,2004,172(3): 1123 - 1126.
  • 9Erdem E, Dikmen G, Atsu N, et al. Telomerase activity in diagnosis of bladder cancer[J] .Stand J Urol Nephrol,2003,37:205- 209.
  • 10Siracusano S, Niccolini B, Knez R, et al. The simultaneous use af telomerase,cytokeratin 20 and CD4 for bladder cancer detection in urine[J]. Eur Urol,2005,47(3) :327 - 333.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部